Exact Sciences Corporation (NASDAQ:EXAS): When Will It Breakeven?
Research Alert: CFRA Retains Buy Opinion On Shares Of Exact Sciences Corporation
Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report
Duolingo, CoreWeave And DexCom Are Among Top 10 Large-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
A Quick Look at Today's Ratings for Exact Sciences(EXAS.US), With a Forecast Between $54 to $90
Exact Sciences Corp Reports Strong Start to 2025
Top Gap Ups and Downs on Friday: AAPL, MSI, ING and More
Express News | Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $75
Exact Sciences Is Maintained at Sector Perform by RBC Capital
Exact Sciences (EXAS) Stock Trades Up, Here Is Why
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Express News | Exact Sciences Shares up 11.2% After Co Raises Annual Rev Forecast, Q1 Rev Beat
Exact Sciences Is Maintained at Outperform by Evercore ISI Group
Cancer Diagnostic Firm Exact Sciences' CEO Says Strong Q1 Paves Way For 'Transformative' 2025, Lifts Annual Guidance
Express News | Evercore ISI Group Maintains Outperform on Exact Sciences, Raises Price Target to $66
Exact Sciences: Strong Q1 Performance and Promising Outlook Justify Buy Rating
RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating
Express News | Baird Maintains Outperform on Exact Sciences, Raises Price Target to $72
Exact Sciences Analyst Ratings